Published in Ann Neurol on March 01, 1992
Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol (2000) 1.55
Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study. Mult Scler (2010) 1.43
The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis (2009) 1.36
The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol (2009) 1.29
Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol (2012) 1.27
Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol (2010) 1.10
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. Arch Neurol (2008) 1.10
Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J Neuroimmunol (2006) 1.03
Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol (2008) 0.99
Developmental stage of oligodendrocytes determines their response to activated microglia in vitro. J Neuroinflammation (2007) 0.98
Multimodal Nonlinear Optical Microscopy and Applications to Central Nervous System Imaging. IEEE J Sel Top Quantum Electron (2008) 0.98
Further evaluation of the Motivational Model of Pain Self-Management: coping with chronic pain in multiple sclerosis. Ann Behav Med (2011) 0.98
Identification of Beck Depression Inventory items related to multiple sclerosis. J Behav Med (1997) 0.95
Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med (2002) 0.91
Pathologic heterogeneity persists in early active multiple sclerosis lesions. Ann Neurol (2014) 0.91
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate. Drug Des Devel Ther (2014) 0.90
Immune regulation of multiple sclerosis by CD8+ T cells. Immunol Res (2014) 0.90
Toll-like receptors in multiple sclerosis. Curr Top Microbiol Immunol (2009) 0.90
PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis. PPAR Res (2008) 0.89
Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. J Neuroimmunol (2010) 0.88
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci (2007) 0.88
Using the international classification of functioning, disability and health to expand understanding of paralysis in the United States through improved surveillance. Disabil Health J (2015) 0.84
Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis. Rehabil Psychol (2015) 0.84
Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders. Interdiscip Perspect Infect Dis (2010) 0.83
Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis. J Nutr (2006) 0.83
Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol (2009) 0.82
Disease modifying agents for multiple sclerosis. Open Neurol J (2010) 0.81
High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance. Anal Chem (2012) 0.81
Disease-modifying Therapies for Multiple Sclerosis. Curr Treat Options Neurol (2003) 0.81
Prevalence of multiple sclerosis. Ann Neurol (1992) 0.81
Multiple sclerosis prevalence in the United States commercially insured population. Neurology (2016) 0.80
Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes. Front Mol Neurosci (2016) 0.80
The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System. Curr Immunol Rev (2009) 0.80
Neuroimmune interactions in a model of multiple sclerosis. Ann N Y Acad Sci (2009) 0.79
Longitudinal predictors of attitudes toward aging among women with multiple sclerosis. Psychol Aging (2008) 0.79
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex. ISRN Neurol (2012) 0.79
Perceptions of Health and Relationships to Disability Measures among People with Multiple Sclerosis. Int J MS Care (2009) 0.78
Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release. J Neuroimmunol (2011) 0.77
Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis. J Spinal Cord Med (2014) 0.77
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis. J Neuroinflammation (2013) 0.76
Towards the use of a lower limb exoskeleton for locomotion assistance in individuals with neuromuscular locomotor deficits. Conf Proc IEEE Eng Med Biol Soc (2012) 0.76
Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation. Front Immunol (2015) 0.76
Exacerbation history is associated with medication and appointment adherence in MS. J Behav Med (2011) 0.76
Task-specific and general cognitive effects in Chiari malformation type I. PLoS One (2014) 0.75
Prevalence of multiple sclerosis. Ann Neurol (1992) 0.75
Prevalence of multiple sclerosis. Ann Neurol (1992) 0.75
Endovascular therapy for chronic cerebrospinal venous insufficiency in multiple sclerosis. Front Neurol (2011) 0.75
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study. Iran J Neurol (2015) 0.75
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Multiple sclerosis. N Engl J Med (2000) 12.69
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology (1996) 10.26
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med (1976) 5.86
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med (1976) 4.67
Prognosis in children with febrile seizures. Pediatrics (1978) 4.38
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler (1999) 3.71
Apgar scores as predictors of chronic neurologic disability. Pediatrics (1981) 3.69
Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med (1986) 3.52
Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis (2001) 3.42
A gender gap in autoimmunity. Science (1999) 3.33
Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature (1978) 3.29
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol (2012) 2.96
Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence. N Engl J Med (1990) 2.85
Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science (1991) 2.77
Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet (1992) 2.69
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
A mutation in the voltage-gated sodium channel gene associated with pyrethroid resistance in Latin American Aedes aegypti. Insect Mol Biol (2007) 2.60
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol (1983) 2.60
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci (1997) 2.44
Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology (1998) 2.38
Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax (1998) 2.33
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology (1998) 2.26
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med (1997) 2.19
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Analysis of clinical trials by treatment actually received: is it really an option? Stat Med (1991) 2.14
White-light filaments for atmospheric analysis. Science (2003) 2.07
Regulating the interpersonal self: strategic self-regulation for coping with rejection sensitivity. J Pers Soc Psychol (2000) 2.05
Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem (1994) 2.04
Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol (1985) 1.98
The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain (1998) 1.96
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys (1994) 1.94
Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci U S A (1994) 1.94
Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science (1982) 1.88
Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.80
Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci (1998) 1.78
Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology (1995) 1.76
Children who "outgrew' cerebral palsy. Pediatrics (1982) 1.70
The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain (2001) 1.70
A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology (1990) 1.66
Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int (2007) 1.65
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol (1996) 1.64
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
Antimitochondrial antibodies in jaundice following drug administration. JAMA (1969) 1.61
Antecedents of cerebral palsy. I. Univariate analysis of risks. Am J Dis Child (1985) 1.59
MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J Neuroimmunol (1987) 1.57
Okadaic acid, a protein phosphatase inhibitor, blocks calcium changes, gene expression, and cell death induced by gibberellin in wheat aleurone cells. Plant Cell (1996) 1.56
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology (2003) 1.56
Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. Eur J Neurol (2010) 1.55
Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology (1986) 1.55
Engineering a homo-ethanol pathway in Escherichia coli: increased glycolytic flux and levels of expression of glycolytic genes during xylose fermentation. J Bacteriol (2001) 1.55
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int (2007) 1.53
Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Mayo Clin Proc (1992) 1.53
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology (2004) 1.51
Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J Virol (1991) 1.50
Teaching community-oriented primary care through longitudinal group projects. Fam Med (1998) 1.50
Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol (1989) 1.49
Febrile seizures and later intellectual performance. Arch Neurol (1978) 1.49
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS. Ann Neurol (2001) 1.46
Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann Neurol (1992) 1.44
The influence of acute and chronic hypercalcemia on the parathyroid hormone response to hypocalcemia in rabbits. Eur J Endocrinol (2002) 1.44
Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis. Mayo Clin Proc (1991) 1.43
Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytol (1999) 1.43
Birth weight and gestational age in children with cerebral palsy or seizure disorders. Am J Dis Child (1979) 1.41
Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. Am J Clin Nutr (1980) 1.40
An ideR mutant of Mycobacterium smegmatis has derepressed siderophore production and an altered oxidative-stress response. Mol Microbiol (1996) 1.39
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
[Is aggressiveness really inhibited in asthmatic adolescents? An epidemiological approach]. Rev Mal Respir (2001) 1.38
Human T-lymphotrophic virus type I and multiple sclerosis. Ann Neurol (1990) 1.37
Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Am J Pathol (1983) 1.37
Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 1.35
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med (2000) 1.34
Obstetric complications as risk factors for cerebral palsy or seizure disorders. JAMA (1984) 1.33
Literacy promotion for Hispanic families in a primary care setting: a randomized, controlled trial. Pediatrics (1999) 1.33
Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer (2012) 1.32
Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science (1986) 1.31
Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology (2004) 1.30
Sample selection and the natural history of disease. Studies of febrile seizures. JAMA (1980) 1.30
Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology (1986) 1.29
YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-kappa B during acute-phase response. Mol Cell Biol (1994) 1.28